Related references
Note: Only part of the references are listed.Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice
Vikas R. Dharnidharka et al.
TRANSPLANT INTERNATIONAL (2018)
Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients
Robert Ettenger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Carpe diemTime to transition from empiric to precision medicine in kidney transplantation
Chris Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity
Chris Wiebe et al.
TRANSPLANTATION (2018)
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
Chris Wiebe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction
Philip J. O'Connell et al.
TRANSPLANTATION (2017)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M. Neuberger et al.
TRANSPLANTATION (2017)
Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients
C. Wehmeier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study
P. Gatault et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward
M. D. Stegall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients
E. Dugast et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching
V. Kosmoliaptsis et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors
Robert C. Williams et al.
TRANSPLANTATION (2016)
The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients With De Novo Donor-Specific Antibody
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients
Donald E. Hricik et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
HLA-DR and -DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study
R. Sapir-Pichhadze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches
A. Djamali et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Biomarker enrichment strategies: matching trial design to biomarker credentials
Boris Freidlin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Class II HLA Epitope Matching-A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
Brian D. Tait et al.
TRANSPLANTATION (2013)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes
Vasilis Kosmoliaptsis et al.
HUMAN IMMUNOLOGY (2011)
HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP
Rene J. Duquesnoy et al.
HUMAN IMMUNOLOGY (2007)
Transplanting the highly sensitized patient: The emory algorithm
R. A. Bray et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Share Paper
